-
Feb 8, 2024 | 
practicalgastro.com | Ken Anderson
Functional abdominal pain (FAP) is a common presentation in both general pediatric and pediatric gastroenterology clinics, and there is no specific test to diagnose this disorder. A clinical history helps in determining if FAP is present, and the authors of this study evaluated the utility of pictograms in assisting the diagnosis of pediatric FAP. This study was prospective and occurred over one year at two academic medical centers in Europe.
-
Feb 8, 2024 | 
practicalgastro.com | Ken Anderson
Investigational drugs opaganib and RHB-107 (upamostat) demonstrate distinct synergistic effect when combined individually with remdesivir, significantly improving potency while maintaining cell viability, in a new U.S. Army-funded and conducted in vitro Ebola virus study Opaganib and RHB-107 are both novel, oral, host-directed, small molecule investigational drugs that are easy to administer and distribute, with demonstrated activity against multiple viral targets, including COVID-19, and are...
-
Feb 8, 2024 | 
practicalgastro.com | Ken Anderson |Douglas G. Adler |Courtney J. Walker
INTRODUCTION Radiofrequency ablation (RFA) was first approved by the United States Food and Drug Administration in 2001 for the treatment of Barrett’s esophagus and for gastric hemostatic applications.1 RFA uses alternating electrical currents in a closed circuit whereby tissues between two electrodes will become coagulated.2 The acute coagulative necrosis occurs when temperatures within tissue are greater than 60 degrees Celsius and results in denaturing of proteins, melting of the plasma...
-
Jan 16, 2024 | 
practicalgastro.com | Ken Anderson
ENTYVIO Is the Only FDA-Approved Ulcerative Colitis Biologic That Offers the Choice of Intravenous or Subcutaneous Maintenance Therapy OSAKA, Japan and CAMBRIDGE, Massachusetts, September 27, 2023 – Takeda (TSE:4502/ NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) administration of ENTYVIO® (vedolizumab) for maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) after induction therapy with ENTYVIO...
-
Jan 16, 2024 | 
practicalgastro.com | Ken Anderson |David Diehl |Douglas G. Adler |Alana Persaud
There are a variety of conditions which may lead to biliary obstruction, usually as a result of malignancy.
-
Jan 12, 2024 | 
practicalgastro.com | Ken Anderson
BRENTWOOD, TENNESSEE, September 14, 2023/EINPresswire.com/ – Cairn Diagnostics, an innovative leader in providing cutting-edge FDA-approved breath tests intended for routine use in diagnostic medicine, today announced the inclusion of its 13C-Spirulina Gastric Emptying Breath Test (GEBT), in recently updated American, European and International Consensus Clinical Guidelines* for evaluation of gastric emptying and diagnosis of gastroparesis (“paralysis of the stomach”) in patients ages 18...
-
Jan 12, 2024 | 
practicalgastro.com | Ken Anderson
• VOQUEZNA, the first and only FDA-approved potassium-competitive acid blocker (PCAB), is now available through major retail pharmacies and BlinkRx, an end-to-end digital fulfillment channel• VOQUEZNA tablets in 30-count bottles are now commercially available for the healing and maintenance of healing of all severities of Erosive GERD, and relief of heartburn associated with Erosive GERD1FLORHAM PARK, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) – Phathom Pharmaceuticals, Inc.
-
Jan 12, 2024 | 
practicalgastro.com | Ken Anderson
Gastric cancer is a leading cause of cancer and cancer related deaths worldwide. While accounting for only 1.5% of cancers in the United States, gastric cancer has one of the highest incidences of disease-associated malnutrition. Understanding the nutrition challenges from tumor related symptoms, side effects of treatments, and post gastrectomy syndrome allows for effective patient care.
-
Jan 12, 2024 | 
practicalgastro.com | Ken Anderson
by Karmen Gill, David Wozny, Satinder GillDisplacement of the stomach into the chest occurs secondary to a weakening of gastricanchoring ligaments and an enlargement of the esophageal hiatus.1 When the stomachmoves above the diaphragm, patients may present with obstruction-like symptoms.
-
Jan 12, 2024 | 
practicalgastro.com | Ken Anderson |Douglas G. Adler |Caleb Hanson
INTRODUCTIONAbdominal trauma affects a wide range of demographics and is considered a significant cause of patient mortality. Abdominal trauma can be difficult to diagnose due to the broad presentation of patients. Many patients with abdominal trauma suffer hepatobiliary and/or pancreatic injury. ERCP is an effective diagnostic tool and treatment modality for patients that have experienced these types of injuries.
